News of Interest
FDA Cleared: EUROLINE ENA Profile 9 Ag [More]
Updated: PLA2R Testing Locations [More]
New FDA Release: PLA2R ELISA [More]
New FDA Release: PLA2R IFA [More]
EUROBlotOne – Fully automated processing of immunoblot tests [More]
News and Events
Wednesday July 26th, 2017
from 12 PM – 1 PM EST.
For free registration, click here
Learn more about autoimmune encephalitides and associated autoantibodies in this rapidly developing field. Maarten Titulaer, MD, PhD is an assistant-professor for neurology and combines clinical work with translational research in autoimmune encephalitis. Previously, he worked with Professor Dr. Dalmau at the University of Pennsylvania and Barcelona to study anti-NMDA receptor and anti-LGI1 encephalitis.
The free webinar, sponsored by EUROIMMUN US, will be presented on
Wednesday July 26th, 2017 from 12 PM – 1 PM EST . For free registration,
click here.If you have any questions regarding the event, please contact us at firstname.lastname@example.org
EUROIMMUN US, Inc., a subsidiary of EUROIMMUN, is a world leader in the field of medical diagnostics. The company’s global success is attributed to its strategic product development in which optimized antigens, as well as patented and licensed technologies, play an important role. EUROIMMUN is consistently expanding its product offerings with new assays to aid in the detection of antibodies associated with autoimmune diseases, infectious diseases, and allergy.